| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Zhengwei Pang CEO | XSHE Exchange | CNE100002P83 ISIN |
| CN Country | 1,418 Employees | 3 Jun 2026 Last Dividend | 5 Jul 2022 Last Split | - IPO Date |
Jiangxi Synergy Pharmaceutical Co., Ltd., established in 2004, is a prominent player in the global pharmaceutical industry, based in Yichun, the People's Republic of China. The company specializes in the manufacturing and global distribution of Active Pharmaceutical Ingredients (APIs), alongside a robust portfolio that includes raw materials, pharmaceutical intermediates, and fine chemicals. Through its extensive product range and steadfast commitment to quality, Jiangxi Synergy Pharmaceutical Co., Ltd. caters to a diverse set of healthcare needs worldwide.
These are the essential components used in the production of pharmaceutical drugs. Jiangxi Synergy Pharmaceutical Co., Ltd. provides a diverse selection of APIs, adhering to strict international quality standards, to pharmaceutical manufacturers globally.
Raw materials are the foundation of any pharmaceutical product. The company offers high-quality raw materials that are crucial for the initial stages of pharmaceutical development, ensuring that the end products are of the highest standard.
These compounds are pivotal in the synthesis of APIs. Jiangxi Synergy Pharmaceutical produces a wide range of intermediates that play a critical role in the pharmaceutical manufacturing process, facilitating the development of effective and safe medications.
Fine chemicals are pure, single substances that are used in specialized applications including pharmaceuticals. The company's fine chemicals are known for their superior quality and are integral to the production of various pharmaceutical formulations.